39 results
Page 2 of 2
8-K
EX-99.2
n1nu72vkfabrn3lfjzn
13 Oct 20
Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
7:40am
8-K
EX-99.1
49fqxbhn7
24 Mar 20
Gossamer Bio Announces Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update
8:45am
10-Q
k0d 22ckwl97y
14 May 19
Quarterly report
7:47am
DEF 14A
piktpyr
30 Apr 19
Definitive proxy
4:04pm
10-K
jl31dxjhehm
22 Mar 19
Annual report
4:45pm
424B4
zqbcurybbt0e5sothl
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
EX-10.5
rsnwtw f8
23 Jan 19
IPO registration (amended)
4:39pm
S-1/A
7arxyi h0
23 Jan 19
IPO registration (amended)
4:39pm
S-1
bvvdplefkz18
21 Dec 18
IPO registration
4:39pm
S-1
EX-10.5
jsytivh0h4t by3zkbr
21 Dec 18
IPO registration
4:39pm
DRS/A
qimxp z7drs7l
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
sl7i1ub8e72
11 Oct 18
Draft registration statement
12:00am